Skip to main content
Clinical Trials/ISRCTN29654603
ISRCTN29654603
Completed
Phase 4

Remifentanil intravenous patient controlled analgesia (PCA) versus intramuscular pethidine for pain relief in labour: a randomised controlled trial

niversity of Birmingham (UK)0 sites400 target enrollmentAugust 8, 2013

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Topic: Reproductive Health and Childbirth
Sponsor
niversity of Birmingham (UK)
Enrollment
400
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

2016 protocol in https://www.ncbi.nlm.nih.gov/pubmed/27955688 2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30115484 2019 qualitative sub-study results in https://pubmed.ncbi.nlm.nih.gov/31874879/ (added 05/11/2020)

Registry
who.int
Start Date
August 8, 2013
End Date
October 18, 2017
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of Birmingham (UK)

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 23/04/2015:
  • 1\. Requesting systemic opioid analgesia
  • 2\. 16 years of age or older
  • 3\. Beyond 37\+0 weeks' gestation
  • 4\. In established labour (defined as regular painful contractions, irrespective of cervical dilatation) with vaginal birth intended
  • 5\. Able to understand all information (written and oral) presented (using an interpreter if necessary) and provide signed consent
  • 6\. Not participating in any other clinical trial of a medicinal product
  • 7\. Live, singleton pregnancy with cephalic presentation
  • Previous inclusion criteria:
  • 1\. Requesting systemic opioid analgesia

Exclusion Criteria

  • Exclusion criteria as of 21/12/2015:
  • 1\. Contraindication to epidural analgesia
  • 2\. Contraindication to intramuscular injection
  • 3\. History of a previous adverse reaction to pethidine or remifentanil
  • 4\. Patients taking any long\-term opioid drug therapy including Methadone
  • 5\. Systemic opioid pain relief in last 4 hours administered by intravenous or intramuscular injection. (Oral medications comprising opioids alone or in combination preparations, administered in this 4 hour period, are permitted).
  • Previous exclusion criteria as of 23/04/2015:
  • 1\. Contraindication to epidural analgesia
  • 2\. Contraindication to intramuscular injection
  • 3\. History of drug sensitivity to pethidine or remifentanil

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Comparing patient satisfaction and costs between epidural and remifentanil during labour in low risk pregnant women.Vergelijking van tevredenheid en kosten tussen epidurale anesthesie met remifentanil bij laag risico zwangeren.This study will assess in women with a request for pain relief during labor the costeffectivenessof RPCA as first choice treatment compared to EA.Epidurale anesthesie meest effectieve vorm van pijnbestrijding. Echter de tevredenheid van de patient tav epidurale anesthesie vergeleken met remifentanil, in dit geval laag risico zwangere, is niet bekend.
NL-OMON20738AMC408
Completed
Not Applicable
RAVEL Trial; Remifentanil patient-controlled analgesia (RPCA) vs epidural analgesia (EA) during labourPain during labour10010273
NL-OMON38234eids Universitair Medisch Centrum1,136
Active, not recruiting
Phase 1
Remifentanil intravenous patient controlled analgesia (PCA) versus Intramuscular Pethidine for pain relief in labour.ChildbirthTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2012-005257-22-GBniversity of Birmingham
Not yet recruiting
Not Applicable
Remifentanil patient gecontroleerde pijnstilling versus epidurale pijnstilling tijdens de bevalling.remifentanil, PCA, epidural, analgesia, labour
NL-OMON28699MC1,136
Completed
Not Applicable
Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the ChildbirthComplication of Labor and/or Delivery
NCT02447757Brno University Hospital66